摘要
目的 研究肝动脉化疗栓塞基础上经皮经肝门静脉灌注化疗治疗晚期肝癌的疗效。方法 对 49例不能手术切除的晚期原发性肝癌随机分组 ,行单纯肝动脉化疗栓塞治疗与在肝动脉化疗栓塞基础上加用经肝门静脉灌注化疗 ,对比分析。结果 肝动脉化疗栓塞基础上经肝门静脉灌注化疗治疗晚期肝癌患者的半年、一年、二年、三年生存率分别为 10 0 %、76 .5 %、35 .2 9%、2 3.5 3% ,AFP及全身转移的发生率明显降低 ,与对照组有显著差异。结论 肝动脉化疗栓塞基础上经肝门静脉灌注化疗治疗晚期肝癌疗效优于单纯性经肝动脉化疗栓塞。
Objective To study the effect of transcatheter chemoembolization(TACE) plus percutaneous transhepatic portochemotherapy(PTP)for the treatment of primary liver cancer(PLC).Methods 49 cases of PLC, were randomly divided into two groups,one group was treated with TACE,and the other with TACE plus PTP.The effects of the two approaches were analyzed and compared.Results The overall 1/2,1,2,3 year survival rates,after using the method of TACE plus PTP,were 100%,76.5%,35.29%,23.53% respectively.The α-FP level and metastatic incidence were decreased significantly when compared with the method of TACE.Conclusion TACE plus PTP for the treatment of PLC is superior to TACE alone.
出处
《中国肿瘤临床与康复》
2001年第4期106-108,共3页
Chinese Journal of Clinical Oncology and Rehabilitation
关键词
肝癌
经导管
肝动脉栓塞
门静脉灌注
治疗
primary liver cancer
interventional therapy
transcatheter chemoembolization
portochemotherapy
